Heron Therapeutics (HRTX) Current Leases (2019 - 2025)
Heron Therapeutics (HRTX) reported Current Leases of $780000.0 for Q3 2025, down 75.99% on a YoY basis from $3.2 million in Q3 2024, and down 49.32% quarter-over-quarter from $1.5 million in Q2 2025.
Heron Therapeutics (HRTX) Current Leases (2019 - 2025) Analysis & Trends
Heron Therapeutics has reported Current Leases for 7 years, with the latest figure at $780000.0 in Q3 2025.
- For the quarter ending Q3 2025, Current Leases fell 75.99% year-over-year to $780000.0; the trailing twelve-month figure through Sep 2025 stood at $780000.0 (down 75.99% YoY), and the FY2024 full-year result was $3.0 million, down 1.24% from the prior year.
- Current Leases for Q3 2025 stood at $780000.0, down from $1.5 million in the prior quarter.
- The five-year high for Current Leases was $3.3 million in Q3 2021, with the low at $780000.0 in Q3 2025.
- Historically, Current Leases has averaged $2.7 million across 5 years, with a median of $2.8 million in 2023.
- Annual changes were most pronounced in 2024 — Current Leases advanced 23.8% — and 2025, when it plunged 75.99%.
- Heron Therapeutics' Current Leases stood at $2.4 million in 2021, then increased by 11.46% to $2.7 million in 2022, then advanced by 14.14% to $3.1 million in 2023, then retreated by 1.24% to $3.0 million in 2024, then tumbled by 74.32% to $780000.0 in 2025.
- The last three Current Leases figures came in at $780000.0 (Q3 2025), $1.5 million (Q2 2025), and $2.3 million (Q1 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Current Leases (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 719,706.53 Bn | 719,706.50 Bn | - | 42,980.09 |
| 2 | Belite Bio | 55,800.00 Bn | 55,800.00 Bn | - | - |
| 3 | Quantum Biopharma | 18,182.30 Bn | 18,182.29 Bn | - | 83,991.00 |
| 4 | Legend Biotech | 3,154.00 Bn | 3,153.71 Bn | 242.10 Mn | 7.40 Mn |
| 5 | Akari Therapeutics | 1,844.30 Bn | 1,844.29 Bn | - | - |
| 6 | Evaxion A | 1,567.96 Bn | 1,567.94 Bn | - | - |
| 7 | Psyence Biomedical | 251.43 Bn | 251.42 Bn | - | - |
| 8 | Vertex Pharmaceuticals | 112.56 Bn | 105.31 Bn | 2.59 Bn | - |
| 9 | Abivax | 94.37 Bn | 94.37 Bn | - | - |
| 10 | Heron Therapeutics | 85.57 Mn | 55.60 Mn | 24.07 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2025 | 780,000.00 |
| Jun 30, 2025 | 1.54 Mn |
| Mar 31, 2025 | 2.29 Mn |
| Dec 31, 2024 | 3.04 Mn |
| Sep 30, 2024 | 3.25 Mn |
| Jun 30, 2024 | 3.19 Mn |
| Mar 31, 2024 | 3.14 Mn |
| Dec 31, 2023 | 3.08 Mn |
| Sep 30, 2023 | 3.00 Mn |
| Jun 30, 2023 | 2.58 Mn |
| Mar 31, 2023 | 2.76 Mn |
| Dec 31, 2022 | 2.69 Mn |
| Sep 30, 2022 | 2.62 Mn |
| Jun 30, 2022 | 2.55 Mn |
| Mar 31, 2022 | 2.48 Mn |
| Dec 31, 2021 | 2.42 Mn |
| Sep 30, 2021 | 3.25 Mn |
| Jun 30, 2021 | 3.16 Mn |
| Mar 31, 2021 | 3.08 Mn |
| Dec 31, 2020 | 3.00 Mn |